Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis

Peter F. Coccia, William Krivit, Jaroslav Cervenka, Carlyle Clawson, John H. Kersey, Taehwan H. Kim, Mark E. Nesbit, Norma K.C. Ramsay, Phyllis I. Warkentin, Steven L. Teitelbaum, Arnold J. Kahn, David M. Brown

Research output: Contribution to journalArticle

338 Citations (Scopus)

Abstract

A five-month-old girl with autosomal-recessive osteopetrosis received a bone-marrow transplant from her five-year-old HLA-MLC-identical brother after preparation with cyclophosphamide and modified total-body irradiation. Engraftment was documented by chromosomal analysis. Anemia, thrombocytopenia, and leukoerythroblastosis corrected within 12 weeks of transplantation. Low serum calcium and elevated serum alkaline and acid phosphatase levels became normal. Serial x-ray studies revealed bony remodeling and new nonsclerotic bone formation. A pretransplantation bone biopsy revealed small marrow spaces, rare marrow elements, increased osteoclasts, and no bony resorption. After transplantation, osteoclasts were actively resorbing bone, and medullary cavities contained normal bone marrow. Fluorescent Y-body analysis after transplantation revealed donor (male) osteoclasts and recipient (female) osteoblasts. Monocyte bactericidal activity, markedly decreased before transplantation, became normal. Vision, hearing, growth, and development were progressively improving 16 months after transplantation. Allogeneic bone-marrow transplantation appears to be the treatment of choice in this fatal disorder. (N Engl J Med. 1980; 302:701–8.) Infantile malignant osteopetrosis (AlbersSchönberg syndrome, or marble bone disease) is a rare autosomal-recessive disorder characterized by dense, sclerotic, fragile, radiopaque bones and associated hematologic and neurologic abnormalities.1,2 Osteopetrosis is thought to result from dysfunction of osteoclasts, the multinucleated giant cells that resorb bone and mineralized cartilage.3,4 Defective bone resorption by osteoclasts, in the presence of normal bone formation by osteoblasts, results in the deposition of excessive mineralized osteoid and cartilage.5 Encroachment on bone-marrow spaces leads to extramedullary hematopoiesis6 and hypersplenism.7 The result is anemia, severe thrombocytopenia, leukoerythroblastosis, and progressive hepatosplenomegaly. Encroachment on cranial-nerve foramina leads to cranial-nerve palsies, optic atrophy.

Original languageEnglish (US)
Pages (from-to)701-708
Number of pages8
JournalNew England Journal of Medicine
Volume302
Issue number13
DOIs
StatePublished - Mar 27 1980

Fingerprint

Osteopetrosis
Osteoclasts
Bone Marrow Transplantation
Transplantation
Bone Marrow
Bone and Bones
Osteoblasts
Osteogenesis
Thrombocytopenia
Anemia
Cranial Nerve Diseases
Optic Atrophy
Cranial Nerves
Whole-Body Irradiation
Homologous Transplantation
Giant Cells
Bone Resorption
Acid Phosphatase
Serum
Growth and Development

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Coccia, P. F., Krivit, W., Cervenka, J., Clawson, C., Kersey, J. H., Kim, T. H., ... Brown, D. M. (1980). Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis. New England Journal of Medicine, 302(13), 701-708. https://doi.org/10.1056/NEJM198003273021301

Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis. / Coccia, Peter F.; Krivit, William; Cervenka, Jaroslav; Clawson, Carlyle; Kersey, John H.; Kim, Taehwan H.; Nesbit, Mark E.; Ramsay, Norma K.C.; Warkentin, Phyllis I.; Teitelbaum, Steven L.; Kahn, Arnold J.; Brown, David M.

In: New England Journal of Medicine, Vol. 302, No. 13, 27.03.1980, p. 701-708.

Research output: Contribution to journalArticle

Coccia, PF, Krivit, W, Cervenka, J, Clawson, C, Kersey, JH, Kim, TH, Nesbit, ME, Ramsay, NKC, Warkentin, PI, Teitelbaum, SL, Kahn, AJ & Brown, DM 1980, 'Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis', New England Journal of Medicine, vol. 302, no. 13, pp. 701-708. https://doi.org/10.1056/NEJM198003273021301
Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH et al. Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis. New England Journal of Medicine. 1980 Mar 27;302(13):701-708. https://doi.org/10.1056/NEJM198003273021301
Coccia, Peter F. ; Krivit, William ; Cervenka, Jaroslav ; Clawson, Carlyle ; Kersey, John H. ; Kim, Taehwan H. ; Nesbit, Mark E. ; Ramsay, Norma K.C. ; Warkentin, Phyllis I. ; Teitelbaum, Steven L. ; Kahn, Arnold J. ; Brown, David M. / Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis. In: New England Journal of Medicine. 1980 ; Vol. 302, No. 13. pp. 701-708.
@article{c875aa38b02f4cbe81c120329b868163,
title = "Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis",
abstract = "A five-month-old girl with autosomal-recessive osteopetrosis received a bone-marrow transplant from her five-year-old HLA-MLC-identical brother after preparation with cyclophosphamide and modified total-body irradiation. Engraftment was documented by chromosomal analysis. Anemia, thrombocytopenia, and leukoerythroblastosis corrected within 12 weeks of transplantation. Low serum calcium and elevated serum alkaline and acid phosphatase levels became normal. Serial x-ray studies revealed bony remodeling and new nonsclerotic bone formation. A pretransplantation bone biopsy revealed small marrow spaces, rare marrow elements, increased osteoclasts, and no bony resorption. After transplantation, osteoclasts were actively resorbing bone, and medullary cavities contained normal bone marrow. Fluorescent Y-body analysis after transplantation revealed donor (male) osteoclasts and recipient (female) osteoblasts. Monocyte bactericidal activity, markedly decreased before transplantation, became normal. Vision, hearing, growth, and development were progressively improving 16 months after transplantation. Allogeneic bone-marrow transplantation appears to be the treatment of choice in this fatal disorder. (N Engl J Med. 1980; 302:701–8.) Infantile malignant osteopetrosis (AlbersSch{\"o}nberg syndrome, or marble bone disease) is a rare autosomal-recessive disorder characterized by dense, sclerotic, fragile, radiopaque bones and associated hematologic and neurologic abnormalities.1,2 Osteopetrosis is thought to result from dysfunction of osteoclasts, the multinucleated giant cells that resorb bone and mineralized cartilage.3,4 Defective bone resorption by osteoclasts, in the presence of normal bone formation by osteoblasts, results in the deposition of excessive mineralized osteoid and cartilage.5 Encroachment on bone-marrow spaces leads to extramedullary hematopoiesis6 and hypersplenism.7 The result is anemia, severe thrombocytopenia, leukoerythroblastosis, and progressive hepatosplenomegaly. Encroachment on cranial-nerve foramina leads to cranial-nerve palsies, optic atrophy.",
author = "Coccia, {Peter F.} and William Krivit and Jaroslav Cervenka and Carlyle Clawson and Kersey, {John H.} and Kim, {Taehwan H.} and Nesbit, {Mark E.} and Ramsay, {Norma K.C.} and Warkentin, {Phyllis I.} and Teitelbaum, {Steven L.} and Kahn, {Arnold J.} and Brown, {David M.}",
year = "1980",
month = "3",
day = "27",
doi = "10.1056/NEJM198003273021301",
language = "English (US)",
volume = "302",
pages = "701--708",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "13",

}

TY - JOUR

T1 - Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis

AU - Coccia, Peter F.

AU - Krivit, William

AU - Cervenka, Jaroslav

AU - Clawson, Carlyle

AU - Kersey, John H.

AU - Kim, Taehwan H.

AU - Nesbit, Mark E.

AU - Ramsay, Norma K.C.

AU - Warkentin, Phyllis I.

AU - Teitelbaum, Steven L.

AU - Kahn, Arnold J.

AU - Brown, David M.

PY - 1980/3/27

Y1 - 1980/3/27

N2 - A five-month-old girl with autosomal-recessive osteopetrosis received a bone-marrow transplant from her five-year-old HLA-MLC-identical brother after preparation with cyclophosphamide and modified total-body irradiation. Engraftment was documented by chromosomal analysis. Anemia, thrombocytopenia, and leukoerythroblastosis corrected within 12 weeks of transplantation. Low serum calcium and elevated serum alkaline and acid phosphatase levels became normal. Serial x-ray studies revealed bony remodeling and new nonsclerotic bone formation. A pretransplantation bone biopsy revealed small marrow spaces, rare marrow elements, increased osteoclasts, and no bony resorption. After transplantation, osteoclasts were actively resorbing bone, and medullary cavities contained normal bone marrow. Fluorescent Y-body analysis after transplantation revealed donor (male) osteoclasts and recipient (female) osteoblasts. Monocyte bactericidal activity, markedly decreased before transplantation, became normal. Vision, hearing, growth, and development were progressively improving 16 months after transplantation. Allogeneic bone-marrow transplantation appears to be the treatment of choice in this fatal disorder. (N Engl J Med. 1980; 302:701–8.) Infantile malignant osteopetrosis (AlbersSchönberg syndrome, or marble bone disease) is a rare autosomal-recessive disorder characterized by dense, sclerotic, fragile, radiopaque bones and associated hematologic and neurologic abnormalities.1,2 Osteopetrosis is thought to result from dysfunction of osteoclasts, the multinucleated giant cells that resorb bone and mineralized cartilage.3,4 Defective bone resorption by osteoclasts, in the presence of normal bone formation by osteoblasts, results in the deposition of excessive mineralized osteoid and cartilage.5 Encroachment on bone-marrow spaces leads to extramedullary hematopoiesis6 and hypersplenism.7 The result is anemia, severe thrombocytopenia, leukoerythroblastosis, and progressive hepatosplenomegaly. Encroachment on cranial-nerve foramina leads to cranial-nerve palsies, optic atrophy.

AB - A five-month-old girl with autosomal-recessive osteopetrosis received a bone-marrow transplant from her five-year-old HLA-MLC-identical brother after preparation with cyclophosphamide and modified total-body irradiation. Engraftment was documented by chromosomal analysis. Anemia, thrombocytopenia, and leukoerythroblastosis corrected within 12 weeks of transplantation. Low serum calcium and elevated serum alkaline and acid phosphatase levels became normal. Serial x-ray studies revealed bony remodeling and new nonsclerotic bone formation. A pretransplantation bone biopsy revealed small marrow spaces, rare marrow elements, increased osteoclasts, and no bony resorption. After transplantation, osteoclasts were actively resorbing bone, and medullary cavities contained normal bone marrow. Fluorescent Y-body analysis after transplantation revealed donor (male) osteoclasts and recipient (female) osteoblasts. Monocyte bactericidal activity, markedly decreased before transplantation, became normal. Vision, hearing, growth, and development were progressively improving 16 months after transplantation. Allogeneic bone-marrow transplantation appears to be the treatment of choice in this fatal disorder. (N Engl J Med. 1980; 302:701–8.) Infantile malignant osteopetrosis (AlbersSchönberg syndrome, or marble bone disease) is a rare autosomal-recessive disorder characterized by dense, sclerotic, fragile, radiopaque bones and associated hematologic and neurologic abnormalities.1,2 Osteopetrosis is thought to result from dysfunction of osteoclasts, the multinucleated giant cells that resorb bone and mineralized cartilage.3,4 Defective bone resorption by osteoclasts, in the presence of normal bone formation by osteoblasts, results in the deposition of excessive mineralized osteoid and cartilage.5 Encroachment on bone-marrow spaces leads to extramedullary hematopoiesis6 and hypersplenism.7 The result is anemia, severe thrombocytopenia, leukoerythroblastosis, and progressive hepatosplenomegaly. Encroachment on cranial-nerve foramina leads to cranial-nerve palsies, optic atrophy.

UR - http://www.scopus.com/inward/record.url?scp=0018891088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018891088&partnerID=8YFLogxK

U2 - 10.1056/NEJM198003273021301

DO - 10.1056/NEJM198003273021301

M3 - Article

C2 - 6986555

AN - SCOPUS:0018891088

VL - 302

SP - 701

EP - 708

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 13

ER -